35e symposium du GRSNC

Home page Speakers Program Registration Abstracts Accommodation Venue Accreditation Contact us Français



About the 35th Symposium

The 35th International Symposium of the Groupe de recherche sur le système nerveux central (GRSNC), entitled "Drugs of abuses and psychiatric diseases: Neurobiological and clinical aspects", will be held on May 6-7, 2013 at Université de Montréal. It is organized by Dr. Louis-Éric Trudeau, Dr. Daniel Lévesque, Dr. Pierre-Paul Rompré, Dr. Anne-Noël Samaha et Dr. Emmanuel Stip (Université de Montréal).

Individuals suffering from psychiatric disorders such as depression or schizophrenia are particularly vulnerable to drug abuse and addiction. This state, where a psychiatric disorder coexists with pathological drug seeking and taking behaviour is known as comorbidity. Comorbidity has major health implications. Patients with such a dual diagnosis suffer more and represent an important therapeutic challenge. At this International Symposium of the GRSNC, held in Montréal, several hypotheses will be discussed. Notably, speakers will debate on the self-medication hypothesis, which suggests that individuals with certain psychiatric diseases abuse drugs to attenuate symptoms of their illness or medication side effects. Other speakers will discuss the possibility that psychiatric disorders and drug addiction are the fruit of a common biological predisposition. The causes of comorbidity are highly complex and controversial: Can drug abuse contribute to the emergence of psychiatric symptoms? Can certain psychiatric medications promote drug taking? What is the addictive potential of certain psychostimulant drugs used in the treatment of attention and hyperactivity disorders? This symposium will bring together basic scientists and clinicians to form an international program covering these issues. The speakers are leading experts in clinical and basic research on issues of comorbidity, and these experts will present the most up to date findings on the links between psychiatric disease and drug addiction. Our hope is that this scientific exchange will educate a broad audience on the dual diagnosis issue and lead to recommendations for new research.

The presentations are divided in two sessions:

  1. Cannabis: Reward and psychosis
  2. Psychostimulants and Nicotine: Reward, synaptic plasticity, and psychiatric disease

See the detailed program.

Submissions are invited for a limited number of poster presentations.

Registration deadline: Thursday, May 2nd 2013

Abstract submission deadline: Wednesday, April 3rd 2013

Symposium venue: Ernest-Cormier Lecture Hall, K-500, Pavillon Roger-Gaudry, Université de Montréal

This activity will be accredited by the Direction du Développement professionnel continu (DPC) of the Faculty of Medicine.


We gratefully acknowledge the financial support of the following organizations:

Sponsors Eli Lilly Canada Chair in Schizophrenia Research Faculté de pharmacie - Université de Montreal FRQS Janssen Society for Neuroscience - Montreal Chapter Institute of Neurosciences, Mental Health and Addiction (INMHA) Groupe de recherche universitaire sur le médicament (GRUM) - Université de Montreal Eli Lilly Canada Faculté de médecine, Vice-décanat à la recherche et à l'innovation scientifique - Université de Montréal Université de Montréal - Vice rectorat à la recherche, création et innovation

© Copyright, GRSNC 2012 GRSNC